Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | THAP9 |
| Upstream (Parents) |
|---|
| (<<) WDFY3 → THAP9 |
| (<<) MYL5 → THAP9 |
| (<<) RUNDC3B → THAP9 |
| (<<) CTH → THAP9 |
| (<<) GCAT → THAP9 |
| (<<) TRIM23 → THAP9 |
| Downstream (Children) |
|---|
| THAP9 → ANKRD12 (>>) |
| THAP9 → ETV3 (>>) |
| THAP9 → CDH10 (>>) |
| THAP9 → SLC22A8 (>>) |
| THAP9 → WNT4 (>>) |
| THAP9 → LOC51145 (>>) |
| THAP9 → CHRNA1 (>>) |
| THAP9 → KCNE1L (>>) |
| THAP9 → CALY (>>) |
| THAP9 → C19orf26 (>>) |
| THAP9 → TMLHE (>>) |
| THAP9 → FAM66D (>>) |
